12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

Zymeworks, Merck deal

Zymeworks said it will receive an undisclosed milestone payment from Merck triggered by the achievement of a research milestone under a 2011 deal...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >